43 Followers on Owler
NovImmune
discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer...
NovImmune
discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer...
News
Feb 20, 2020
startupticker
NovImmune: Novimmune's successor company receives milestone payment from Takeda
Jun 13, 2019
BioPortfolio
NovImmune: Sobi acquire Novimmune in deal worth more than £400 million httpbit.ly31xbFeS pharma biotech immunologypic.twitter.commUGnxDDLJC
Jun 13, 2019
BioCentury
NovImmune: Sobi buying Novimmune assets as it refocuses R&D
Jun 12, 2019
Reuters
NovImmune: Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
Mar 26, 2019
Pharmabiz
NovImmune: Sobi, Novimmune select Honourees for 2019 NORD Rare Impact Award for Gamifant
Dec 04, 2018
PR Newswire
Press Release: NovImmune : Data Presented at ASH Support Emapalumab as an Innovative, Targeted Therapeutic Option for Primary HLH
Nov 23, 2018
BioPortfolio
NovImmune: Sobi Novimmune announce US FDA approves Gamifant to treat primary HLH
Nov 22, 2018
Cision
NovImmune: Late-breaking abstract at ASH supports evidence on transformative first-ever treatment in primary HLH
Aug 25, 2018
Pharmabiz
NovImmune: Sobi acquires global rights for emapalumab from Novimmune
Aug 23, 2018
startupticker
NovImmune: Novimmune's lead drug on the way to the market
NovImmune Competitors
1
2
3
4
5
6
7
8
9
Looking for similar companies to NovImmune?
NovImmune News
NovImmune Press Releases
NovImmune Videos
NovImmune Headquarters
NovImmune Summary
ABOUT
Overview
NovImmune discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. NovImmune was founded in 1998. NovImmune's headquarters is located in Plan-les-Ouates, Geneva, CH 1228. NovImmune's...CEO
NovImmune's CEO, Erik Trock Jansen, currently has an approval rating of 88%. NovImmune's primary competitors are MacroGenics, Endocyte, Kite Pharma and 6 more.Website
novimmune.comCompetitors
View 9 NovImmune competitors here.Acquisitions
There have been no acquisitions found related to NovImmuneInvestments
Recent investment data cannot be found related to NovImmuneFrequently Asked Questions about NovImmune
When was NovImmune founded?
NovImmune was founded in 1998Who is NovImmune's CEO?
NovImmune's CEO is Erik Trock JansenHow much revenue does NovImmune generate?
NovImmune generates $40M in revenueHow much funding does NovImmune have?
NovImmune has historically raised $248.6M in funding
Where is NovImmune's headquarters?
NovImmune's headquarters is in Plan-les-Ouates Geneva, CHHow many employees does NovImmune have?
NovImmune has 150 employeesWhat sector does NovImmune operate in?
NovImmune is in BiotechnologyWho are NovImmune's competitors?
NovImmune's top competitors are MacroGenics, Endocyte, Kite Pharma